Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*
about
Aniracetam does not alter cognitive and affective behavior in adult C57BL/6J miceDeep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells.Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunctionPerspectives for treating Alzheimer's disease: a review on promising pharmacological substances.Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy.
P2860
Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*
description
im Februar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 26 February 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2011
@uk
name
Clinical Efficacy of Aniraceta ...... ent: A Comparative Open Study*
@en
Clinical Efficacy of Aniraceta ...... ent: A Comparative Open Study*
@nl
type
label
Clinical Efficacy of Aniraceta ...... ent: A Comparative Open Study*
@en
Clinical Efficacy of Aniraceta ...... ent: A Comparative Open Study*
@nl
prefLabel
Clinical Efficacy of Aniraceta ...... ent: A Comparative Open Study*
@en
Clinical Efficacy of Aniraceta ...... ent: A Comparative Open Study*
@nl
P2860
P1476
Clinical efficacy of aniraceta ...... ment: a comparative open study
@en
P2093
Chaido Messini
Chrysi C Koliaki
P2860
P304
P356
10.1111/J.1755-5949.2010.00244.X
P577
2011-02-26T00:00:00Z